201 related articles for article (PubMed ID: 23748572)
1. A panel of four cytokines predicts the prognosis of patients with malignant gliomas.
Lin Y; Zhang G; Zhang J; Gao G; Li M; Chen Y; Wang J; Li G; Song SW; Qiu X; Wang Y; Jiang T
J Neurooncol; 2013 Sep; 114(2):199-208. PubMed ID: 23748572
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
Chen T; Wang XY; Li C; Xu SJ
Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
[TBL] [Abstract][Full Text] [Related]
3. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
Gandhi P; Khare R; Garg N
J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
[TBL] [Abstract][Full Text] [Related]
5. An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.
Nijaguna MB; Patil V; Hegde AS; Chandramouli BA; Arivazhagan A; Santosh V; Somasundaram K
PLoS One; 2015; 10(9):e0137524. PubMed ID: 26390214
[TBL] [Abstract][Full Text] [Related]
6. Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas.
Iwamoto FM; Hottinger AF; Karimi S; Riedel E; Dantis J; Jahdi M; Panageas KS; Lassman AB; Abrey LE; Fleisher M; DeAngelis LM; Holland EC; Hormigo A
Neuro Oncol; 2011 Nov; 13(11):1244-51. PubMed ID: 21831900
[TBL] [Abstract][Full Text] [Related]
7. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
[TBL] [Abstract][Full Text] [Related]
8. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
9. Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas.
Lin Y; Jiang T; Zhou K; Xu L; Chen B; Li G; Qiu X; Jiang T; Zhang W; Song SW
Neuro Oncol; 2009 Oct; 11(5):468-76. PubMed ID: 19164435
[TBL] [Abstract][Full Text] [Related]
10. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
[TBL] [Abstract][Full Text] [Related]
11. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.
Chaichana KL; McGirt MJ; Laterra J; Olivi A; Quiñones-Hinojosa A
J Neurosurg; 2010 Jan; 112(1):10-7. PubMed ID: 19361270
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
14. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
16. A multivariate analysis of the prognostic factors of grade III gliomas.
Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
[TBL] [Abstract][Full Text] [Related]
17. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
[TBL] [Abstract][Full Text] [Related]
19. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
20. Impact of Resection on Survival of Isocitrate Dehydrogenase 1-Mutated World Health Organization Grade II Astrocytoma After Malignant Progression.
Grau SJ; Hampl JA; Kohl AC; Timmer M; Duval IV; Blau T; Ruge MI; Goldbrunner RH
World Neurosurg; 2017 Jul; 103():180-185. PubMed ID: 28377251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
